Overview

Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel

Status:
Completed

Trial end date:
2020-09-04

Target enrollment:

Participant gender:

Summary

Explore the randomized, controlled, double-blind design targeted for the final clinical trial to assess the acceptability of interventions and clinical outcome measures and to provide data making it possible to estimate the parameters necessary for the preparation, modification or even abandonment of the final study.

Phase:

Phase 3

Details

Lead Sponsor:

Ciusss de L'Est de l'Île de Montréal

Treatments:

Albumin-Bound Paclitaxel
Cetirizine
Diphenhydramine
Paclitaxel
Promethazine